Research digest: pioneering an oral GLP-1 receptor agonist

研究简报: 全新型口服GLP-1受体激动剂的研发

Mark A Atkinson

The lancet. Diabetes & endocrinology. 2019 Dec;7(12):897.

Preoperative GLP-1 Receptor Agonist Use and Risk of Postoperative Respiratory Complications

术前使用GLP-1受体激动剂与术后呼吸道并发症的风险关系

Anjali A Dixit et al.

JAMA. 2024 May 21;331(19):1672-1673.

A Case of Dulaglutide-Induced Acute Interstitial Nephritis After Many Years of Treatment With an Alternate GLP-1 Receptor Agonist

用另一种GLP-1受体激动剂治疗多年后出现Dulaglutide诱发的急性间质性肾炎一例报告

Muralikrishna Gangadharan Komala

Clinical diabetes : a publication of the American Diabetes Association. 2022 Fall;40(4):508-510.

Dulaglutide

杜拉格利汀

.

GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease

GLP-1受体激动剂与非酒精性脂肪肝病

Jinmi Lee et al.

Diabetes & metabolism journal. 2012 Aug;36(4):262-7.

GLP-1 receptor agonist attenuates tubular cell ferroptosis in diabetes via enhancing AMPK-fatty acid metabolism pathway through macropinocytosis

GLP-1受体激动剂通过巨胞饮作用增强AMPK-脂肪酸代谢途径减轻糖尿病中的管细胞铁死亡

Rui Shen et al.

Biochimica et biophysica acta. Molecular basis of disease. 2024 Apr;1870(4):167060.

Successful Use of a GLP-1 Receptor Agonist as Add-on Therapy to Glibenclamide in a Young Adult With KCNJ11 Permanent Neonatal Diabetes

用于治疗KCNJ11永久新生儿糖尿病的胰高血糖素样肽-1受体激动剂与格列本脲联合应用的病例报告

Mairéad T Crowley et al.

Diabetes care. 2024 Dec 1;47(12):e102-e103.

The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial

艾塞那肽对特发性颅内高压影响的随机临床试验

James L Mitchell et al.

Brain : a journal of neurology. 2023 May 2;146(5):1821-1830.